Centennial Wealth Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
CWP
FWIA
ORIO
CNB
KC
WAM
Centennial Wealth Advisory's PFE Position: Q2 2026 in Review
Centennial Wealth Advisory increased its Pfizer (PFE) stake by 5.1% in Q2 2026, buying an estimated $60.7K and bringing the position to 47,757 shares worth $1.15M. The position accounts for 0.25% of the portfolio, ranked #57.
Centennial Wealth Advisory first reported a position in PFE in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.28M in Q1 2026. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Centennial Wealth Advisory held 47,757 shares of Pfizer worth $1.15M as of Q2 2026.
- Centennial Wealth Advisory bought 2,320 Pfizer shares in Q2 2026, an estimated $60.7K.
- Pfizer made up 0.25% of Centennial Wealth Advisory's portfolio in Q2 2026, its #57 holding.
- Centennial Wealth Advisory first reported a position in Pfizer in Q2 2022 and has held it in 14 quarters since.
- Centennial Wealth Advisory's Pfizer position peaked at $1.28M in Q1 2026.
- 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Centennial Wealth Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.